Sphingomonas Paucimobilis Complicating Vaginal Fluid Cultivation. A Rare Case

Authors

Chrisostomos Sofoudis 1*, Andria Peraki 1, Angeliki Mavroidi2, Evangelia Platsouka2 and Efthimios Papamargaritis1
1 Department of Obstetrics and Gynecology, Konstandopoulio General Hospital, Athens, Greece.
2 Department of Microbiology, Konstandopoulio General Hospital, Athens, Greece.

Article Information

*Corresponding Author: Chrisostomos Sofoudis, Department of Obstetrics and Gynecology, Konstandopoulio General Hospital, Athens, Greece.
Received date: January 11, 2021
Accepted date: February 18, 2021
Published date: February 24, 2021

Citation:  Sofoudis C, Peraki A, Mavroidi A, Platsouka E and Papamargaritis E, Sphingomonas Paucimobilis Complicating Vaginal Fluid Cultivation. A Rare Case. International J of Clinical Gynaecology and Obstetrics, 2(1); DOI: http;//doi.org/03.2021/1.1009.
Copyright: © 2021 Chrisostomos Sofoudis. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Sphingomonas paucimobilis represents an aerobic Gram-negative bacillus that is gaining recognition as an important human pathogen.

These species are widely distributed in both natural environment and hospitals.

They appear as opportunistic pathogen that take advantage of underlying conditions and diseases. Regardless of the clinical significance, pathogenic mechanism varies throughout current bibliography.

Aim of our study, reflects presentation of a rare case of an out-patient clinical asymptomatic, with vaginal culture positive for this rare microorganism, S. paucimobilis.

Assiduous diagnosis and therapeutic mapping consist necessary conditions of effective treatment.


Keywords: spingomonas paucimobilis, gram-negative microorganism, vaginal culture, asymptomatic

Introduction

Sphingomonas paucimobilis depicts a glucose-no fermenting, strictly aerobic, Gram-negative bacillus that thrives in the natural environment, especially in water and soil.

At the same time, it has also been isolated from hospital settings, including hospital water systems, distilled water, dialysis fluid, nebulizers, and other respiratory therapy equipment. [1-4]

S. paucimobilis has the property of being found in low carbon environment (oligotropic). It is used for bioremediation of the environment for its ability to decompose aromatic compounds. [5]

Additionally, is characterized by catalase and oxidase activity, yellow pigment production, and slow motility with single polar flagellum. [6]

S. paucimobilis was initially reported to cause human infection in 1979. It consists an opportunistic pathogen, isolated from blood, sputum, urine, wound, bile, cerebrospinal fluid, vagina, and cervix.

Its virulence is thought to be low, and identification of the organism from clinical specimen is rare.

However, it is associated with great variety of infections, concerning community-acquired and health care-associated ones.

Specifically, literature has documented bacteremia, pneumonia, catheter related infections, meningitis, peritonitis, osteomyelitis, septic arthritis, postoperative endophthalmitis, lung empyema, splenic abscesses, urinary tract infections, and biliary tract infections. [7-26]

Community-acquired infection, diabetes mellitus, and alcoholism have been established as significant risk factors for primary pseudomonada paucimobilis bacteremia. [27]

Case

We present a case of a 72- year old female patient (G4, P4), with history of hypertension and hypothyroidism pharmaceutically regulated, admitted at our Department with ultrasonography depiction of uterine cavity filled with fluid presence. 

Pap smear revealed no signs of malignancy. Abdominal MRI depiction confirmed fluid presence inside uterine cavity along with intense heterogeneity of uterine configuration.

Patient underwent hysteroscopic evaluation of uterine cavity along with diagnostic curettage. 

During cervical penetration, a massive amount of yellow-pigmented fluid was noticed.

A cotton swab filled with suspected fluid sent for microbiologic evaluation and cultivation.

The sample from pus was cultured  at 35 0C for 24-hours and  yielded yellow-pigmented, smoothed, convex, non- haemolytic, oxidase- and catalase-positive colonies, growing on blood agar (Figure I) and chocolate agar plates, but not on McConkey agar plate.

Figure I:  S. paucimobilis culture on blood agar showing yellow-pigmented colonies.

Gram stain showed gram-negative bacilli (Figure II), which were identified as Sphingomonas paucimobilis by the VITEK® 2 Compact15 automated system (Biomereux, France).

Figure II: Gram stain of the gram-negative bacillus S. paucimobilis.

Antibiotic susceptibility testing was performed both by the VITEK® 2 Compact15 automated system and the ETEST®  method (Biomereux, France) on Mueller Hinton agar plates using an inoculum of 0.5 McFarland and a 24-hour incubation at 35 0C.

The isolate was characterised as: resistant to ceftazidime (MIC> 32μg/ml) and piperacillin/tazobactam (MIC> 16μg/ml, ciprofloxacin (MIC=1 μg/ml), susceptible-increased exposure to imipenem (MIC=2 μg/ml), and susceptible to meropenem (MIC=1 μg/ml) and amikacin (MIC<=2 μg/ml), according to the EUCAST 2020 criteria for Pseudomonas aeruginosa.

Hysteroscopic evaluation of uterine cavity did not reveal signs of uterine malignancy. Histologic examination of diagnostic curettage consisted  areas of cervical and endometrial infection.

Patient discharged from hospital the folowwing day in good clinical condition. She reveived tb Amoxicillin and clavounic acid (Augmentin) for 10 days, 2 times per day.

Follow up with new vaginal fluid cultivation did not reveal presence of S. paucimobilis

Discussion

S.paucimobilis consists  an aerobic, non-fermentative gram negative bacterium, widely distributed in the natural environment (e.g. water, soil).

It represents an opportunistic pathogen, considered to originate from contaminated hospital equipment or manipulation of some medical devices, causing hospital infections in immune-compromised patients and very rare in healthy persons.

Balkwill et al. reported that, although there may be certain predisposing conditions, it may not be always possible to determine the source of the infection. [28]   

Lin et al. evaluated 16 cases with S. paucimobilis bacteremia and found a malignancy rate of 57.1% and a diabetes rate of 40.5%. [29]

So far, a variety of infections have been reported with this microorganism, such as sepsis, septic pulmonary embolism, septic arthritis, peritonitis, and endophthalmitis.

According to Cheong et al., the most common type of infection was catheter-related infection (34.8%) followed by primary bacteremia (26.1%), continuous ambulatory peritoneal dialysis peritonitis (13.0%), and gastrointestinal infection (8.7%). [30]

Disclosure of interest: All authors declare any financial interest with respect to this manuscript.

Conclusion

S. paucimobilis represnts a Gram negative bacillus, relative rare isolated in gynecologic speciments.

Assiduous therapeutic mapping consists ultimate scope, in order to avoid systemic infections and increase of patient’s quality of life.

References

  1. Phillips G, Fleming LW, Stewart WK, Hudson S. Pseudomonas paucimobilis contamination in haemodialysis fluid. J Hosp Infect 1991; 17:70–1.
  2. Perez del Molino ML, Garcia-Ramos R. Pseudomonas paucimobilis in purified water for hospital use. J Hosp Infect 1989; 14:373–4.
  3. Lemaitre D, Elaichouni A, Hundhausen M, Claeys G, Vanhaesebrouck P, Vaneechoutte M, et al. Tracheal colonization with Sphingomonas paucimobilis in mechanically ventilated neonates due to contaminated ventilator temperature probes. J Hosp Infect 1996; 32:199–206.
  4. Oie S, Makieda D, Ishida S, Okano Y, Kamiya A. Microbial contamination of nebulization solution and its measures. Biol Pharm Bull 2006; 29:503–7.
  5. Coppotelli BM, Ibarrolaza A, Dias RL, Del Panno MT, BertheCorti L, Morelli IS. Study of the     degradation activity and the strategies to promote the bioavailability of phenanthrene by Sphingomonas paucimobilis strain 20006FA. Microb Ecol 2010; 59:266e76.
  6. Yabuuchi E, Yano I, Oyaizu H, Hashimoto Y, Ezaki T, Yamamoto H. Proposals of Sphingomonas paucimobilis gen. nov. and comb. nov., Sphingomonas parapaucimobilis sp. nov., Sphingomonas yanoikuyae sp. nov., Sphingomonas adhaesiva sp. nov., Sphingomonas capsulata comb. nov., and two genospecies of the genus Sphingomonas. Microbiol Immunol 1990; 34:99e119
  7. Southern PM Jr, Kutscher AE. Pseudomonas paucimobilis bacteremia. J Clin Microbiol 1981; 13:1070–3.
  8. Morrison AJ Jr, Shulman JA. Community-acquired bloodstream infection caused by Pseudomonas paucimobilis: case report and review of the literature. J Clin Microbiol 1986; 24:853–5.
  9. Calubiran OV, Schoch PE, Cunha BA. Pseudomonas paucimobilis bacteraemia associated with haemodialysis. J Hosp Infect 1990; 15:383–8.
  10. Reina J, Bassa A, Llompart I, Portela D, Borrell N. Infections with Pseudomonas paucimobilis: report of four cases and review. Rev Infect Dis 1991; 13:1072–6.
  11. Decker CF, Hawkins RE, Simon GL. Infections with Pseudomonas paucimobilis. Clin Infect Dis 1992; 14:783–4.
  12. Casadevall A, Freundlich LF, Pirofski L. Septic shock caused by Pseudomonas paucimobilis. Clin Infect Dis 1992; 14:784.
  13. Salazar R, Martino R, Sureda A, Brunet S, Subir M, DomingoAlbs A. Catheter-related bacteremia due to Pseudomonas paucimobilis in neutropenic cancer patients: report of two cases. Clin Infect Dis 1995; 20:1573–4.
  14. Kristensen B, Tingsgaard LK, Ejlertsen T. Self-induced bacteremia. Case report. APMIS 1995; 103:475–6.
  15. Martino R, Martínez C, Pericas R, Salazar R, Solá C, Brunet S, et al. Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors. Eur J Clin Microbiol Infect Dis 1996; 15:610–5.
  16. Hsueh PR, Teng LJ, Yang PC, Chen YC, Pan HJ, Ho SW, et al. Nosocomial infections caused by Sphingomonas paucimobilis: clinical features and microbiological characteristics. Clin Infect Dis 1998; 26:676–81.
  17. Perola O, Nousiainen T, Suomalainen S, Aukee S, Kärkkäinen UM, Kauppinen J, et al. Recurrent Sphingomonas paucimobilis-bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients. J Hosp Infect 2002; 50:196–201.
  18. Al-Anazi KA, Abu Jafar S, Al-Jasser AM, Al-Shangeeti A, Chaudri NA, Al Jurf MD, et al. Septic shock caused by Sphingomonas paucimobilis bacteremia in a patient with hematopoietic stem cell transplantation. Transpl Infect Dis 2008; 10:142–4.
  19. Kilic A, Senses Z, Kurekci AE, Aydogan H, Sener K, Kismet E, et al. Nosocomial outbreak of Sphingomonas paucimobilis bacteremia in a hemato/oncology unit. Jpn J Infect Dis 2007; 60:394–6.
  20. Charity RM, Foukas AF. Osteomyelitis and secondary septic arthritis caused by Sphingomonas paucimobilis. Infection 2005; 33:93–5.
  21. Adams WE, Habib M, Berrington A, Koerner R, Steel DH. Postoperative endophthalmitis caused by Sphingomonas paucimobilis. J Cataract Refract Surg 2006; 32:1238–40.
  22. Phillips G, Fleming LW, Stewart WK. Pseudomonas paucimobilis peritonitis in a patient on CAPD successfully treated with ciprofloxacin and netilmicin. Eur J Clin Microbiol Infect Dis 1990; 9:630–1. 23.
  23. Ensminger SA, Wright RS, Baddour LM, Afessa B. Suspected ventilator-associated pneumonia in cardiac patients admitted to the coronary care unit. Mayo Clin Proc 2006; 81:32–5.
  24. Glupczynski Y, Hansen W, Dratwa M, Tielemans C, Wens R, Collart F, et al. Pseudomonas paucimobilis peritonitis in patients treated by peritoneal dialysis. Clin Microbiol 1984; 20:1225–6.
  25. Studemeister AE, Beilke MA, Kirmani N. Splenic abscess due to Clostridium difficile and Pseudomonas paucimobilis. Am J Gastroenterol 1987; 82:389–90.
  26. Cover TL, Appelbaum PC, Aber RC. Pseudomonas paucimobilis empyema after cardiac transplantation. South Med J 1988; 81:796–8
  27. Han-Siong Toh a, Hung-Tze Tay b, Wei-Khie Kuar b, Tzu-Chieh Weng a, Hung-Jen Tang a, Che-Kim Tan b, Risk factors associated with Sphingomonas paucimobilis infection, Journal of Microbiology, Immunology and Infection (2011)44, 289-295
  28. Balkwill DL, Frederikson JK, Romine MF: Sphingomonas and related genera in Dworkin M, Falkow S, Rosenberg E, Schleifer KH, Stackebrand R (eds): The Prokaryotes: An Electronic Revolving Resource for the Microbiological Community, 3rd ed. New York: Springer Verlag, 2006, pp605-629
  29. Lin JN, Lai CH, Chen YH, Lin HL, Huang CK, Chen WF, et al.: Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review. J Microbiol Immunol Infect 43: 35-42, 2010
  30. Cheong HS, Wi YM, Moon SY, Kang CI, Son JS, Ko KS, et al.Clinical features and treatment outcomes of infections causedby Sphingomonas paucimobilis.Infect Control Hosp Epidemiol2008;29:990.